33036493|t|Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells.
33036493|a|Mitochondrial dysfunction is a key element in the pathogenesis of neurodegenerative disorders, such as riboflavin transporter deficiency (RTD). This is a rare, childhood-onset disease characterized by motoneuron degeneration and caused by mutations in SLC52A2 and SLC52A3, encoding riboflavin (RF) transporters (RFVT2 and RFVT3, respectively), resulting in muscle weakness, ponto-bulbar paralysis and sensorineural deafness. Based on previous findings, which document the contribution of oxidative stress in RTD pathogenesis, we tested possible beneficial effects of several antioxidants (Vitamin C, Idebenone, Coenzyme Q10 and EPI-743, either alone or in combination with RF) on the morphology and function of neurons derived from induced pluripotent stem cells (iPSCs) from two RTD patients. To identify possible improvement of the neuronal morphotype, neurite length was measured by confocal microscopy after beta-III tubulin immunofluorescent staining. Neuronal function was evaluated by determining superoxide anion generation by MitoSOX assay and intracellular calcium (Ca2+) levels, using the Fluo-4 probe. Among the antioxidants tested, EPI-743 restored the redox status, improved neurite length and ameliorated intracellular calcium influx into RTD motoneurons. In conclusion, we suggest that antioxidant supplementation may have a role in RTD treatment.
33036493	28	61	Riboflavin Transporter Deficiency	Disease	MESH:D012257
33036493	139	164	Mitochondrial dysfunction	Disease	MESH:D028361
33036493	205	232	neurodegenerative disorders	Disease	MESH:D019636
33036493	242	275	riboflavin transporter deficiency	Disease	MESH:D012257
33036493	277	280	RTD	Disease	MESH:D012257
33036493	340	363	motoneuron degeneration	Disease	MESH:D009410
33036493	391	398	SLC52A2	Gene	79581
33036493	403	410	SLC52A3	Gene	113278
33036493	451	456	RFVT2	Gene	79581
33036493	461	466	RFVT3	Gene	113278
33036493	496	511	muscle weakness	Disease	MESH:D018908
33036493	513	535	ponto-bulbar paralysis	Disease	MESH:D010244
33036493	540	562	sensorineural deafness	Disease	MESH:D006319
33036493	647	650	RTD	Disease	MESH:D012257
33036493	728	737	Vitamin C	Chemical	MESH:D001205
33036493	739	748	Idebenone	Chemical	MESH:C036619
33036493	750	762	Coenzyme Q10	Chemical	MESH:C024989
33036493	767	774	EPI-743	Chemical	MESH:C571746
33036493	919	922	RTD	Disease	MESH:D012257
33036493	923	931	patients	Species	9606
33036493	1143	1159	superoxide anion	Chemical	MESH:D013481
33036493	1206	1213	calcium	Chemical	MESH:D002118
33036493	1215	1219	Ca2+	Chemical	-
33036493	1239	1245	Fluo-4	Chemical	MESH:C409648
33036493	1284	1291	EPI-743	Chemical	MESH:C571746
33036493	1373	1380	calcium	Chemical	MESH:D002118
33036493	1393	1396	RTD	Disease	MESH:D012257
33036493	1488	1491	RTD	Disease	MESH:D012257
33036493	Association	MESH:D006319	113278
33036493	Association	MESH:D010244	79581
33036493	Association	MESH:D018908	79581
33036493	Association	MESH:D012257	79581
33036493	Association	MESH:D010244	113278
33036493	Negative_Correlation	MESH:C571746	MESH:D012257
33036493	Association	MESH:D006319	79581
33036493	Negative_Correlation	MESH:C571746	MESH:D002118
33036493	Association	MESH:D018908	113278
33036493	Association	MESH:D002118	MESH:D012257
33036493	Association	MESH:D012257	113278

